Skip to main content

Table 1 Clinical characteristics of systemic disease in SCNSL patients

From: Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study

Characteristics

N

%

Age

 Median (range)

58 (20–72)

 

 ≤ 60

10

52.6

 > 60

9

47.4

Gender

 Male

9

47.4

 Female

10

52.6

Initial disease location

 Breasts

3

15.8

 Testis

2

10.5

 Lymph node

11

57.9

 Others

3

15.9

Ann Arbor stage

 I–II

5

26.3

 III–IV

14

73.7

Treatment of initial disease

 R-CHOP like regimen

9

47.4

 Other regimen

10

52.6

CNS prophylaxis

 Yes

2

10.5

 No

17

89.5